Biotechnology News and Research RSS Feed - Biotechnology News and Research

Mitosis study identifies new potential target for cancer therapy

Mitosis study identifies new potential target for cancer therapy

Structural biologists show in a new study that an apparently key step in the process of cell division depends on a unique interaction among specific proteins, including one that is strongly linked to cancer. Their hope now is that the detailed new characterization of the interaction will make it a target for exploring a new cancer therapy. [More]
Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs. [More]
Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

The Oswaldo Cruz Foundation at Rio de Janeiro, Brazil, will start the phase II clinical trials of a vaccine for schistosomiasis, called 'Sm14 Vaccine'. [More]
Novel inhibitory brain receptor reduces seizure-like activity in pubertal mice

Novel inhibitory brain receptor reduces seizure-like activity in pubertal mice

More than half of children with epilepsy outgrow their seizures, yet the mechanism underlying this remission is unknown. [More]
Researchers discover novel pathway for immune recovery following bone-marrow transplantation

Researchers discover novel pathway for immune recovery following bone-marrow transplantation

New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system. [More]
New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials

New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials

A University of Central Florida cancer researcher has discovered a way to kill spreading breast cancer cells and her new technology has generated a licensing agreement that will accelerate the therapy's path to clinical trials. [More]
HMS study reveals key instigator of nerve cell damage in ALS patients

HMS study reveals key instigator of nerve cell damage in ALS patients

Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder. [More]
Chris Molloy appointed new CEO of Medicines Discovery Catapult

Chris Molloy appointed new CEO of Medicines Discovery Catapult

The Medicines Discovery Catapult has appointed its first Chief Executive Officer. Chris Molloy, who has more than 25 years’ experience in the international life science industry, will lead the MDC in developing new approaches for the discovery and early development of new medicines. [More]
Researchers investigate link between diet, obesity-linked Type 2 diabetes, and spinal disc degeneration

Researchers investigate link between diet, obesity-linked Type 2 diabetes, and spinal disc degeneration

Can a diet high in processed fat and sugar and Type 2 diabetes cause degeneration of intervertebral discs in the spine? If so, what is happening, and can it be prevented? As part of an ongoing collaboration between Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai - a partnership that draws upon the expertise of both schools to address significant health problems - researchers hope to answer those questions by investigating the link between diet, obesity-linked Type 2 diabetes, and intervertebral disc degeneration. [More]
Genekam develops first therapeutic molecule candidate for Zika viruses

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. [More]
Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Fruit fly models may help scientists understand underlying mechanism of HPV-induced cancer

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States and has been identified as a primary cause of cervical cancer in women. [More]
Novel marine natural product appears to reduce pancreatic tumor size

Novel marine natural product appears to reduce pancreatic tumor size

Scientists at Florida Atlantic University's Harbor Branch Oceanographic Institute found that a deep-water marine sponge collected off of Fort Lauderdale's coast contains leiodermatolide, a natural product that has the ability to inhibit the growth of cancer cells as well as block cancer cells from dividing using extremely low concentrations of the compound. [More]
New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

New ATA recommendations offer guidance for managing all forms of thyrotoxicosis

New evidence-based recommendations from the American Thyroid Association provide guidance to clinicians in the management of patients with all forms of thyrotoxicosis (excessively high thyroid hormone activity), including hyperthyroidism. [More]
Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million. [More]
INTEGRA launches new version of popular pipette range with motorized tip spacing technology

INTEGRA launches new version of popular pipette range with motorized tip spacing technology

INTEGRA announces a new generation version of its popular VOYAGER pipette range that features unique motorized tip spacing technology. [More]
Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports. [More]
Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Before I explain the discovery, I would take a step back and explain an interesting event that takes place in the cancer cells. Normal cells follow a rapid and irreversible process to efficiently eradicate dysfunctional cells. This is a natural process by which damaged cells commit ‘suicide’. This process is known as apoptosis or programmed cell death. [More]
New model of Williams syndrome may shed light on neurobiology of the human social brain

New model of Williams syndrome may shed light on neurobiology of the human social brain

In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain. [More]
Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic has launched a new type of blood test that will be used to predict adverse cardiovascular events in patients with progressing coronary artery disease (CAD). [More]
Sharing of patients' stem cells could boost bipolar disorder research

Sharing of patients' stem cells could boost bipolar disorder research

Stem cells from patients with bipolar disorder are being made available to scientists around the world to boost research into the condition. [More]
Advertisement
Advertisement